Beijing Wantai Biological Pharmacy Enterprise Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zhiming Jiang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1yr |
| CEO ownership | n/a |
| Management average tenure | 1yr |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) Analysts Are Reducing Their Forecasts For This Year
Jul 26
These 4 Measures Indicate That Beijing Wantai Biological Pharmacy Enterprise (SHSE:603392) Is Using Debt Reasonably Well
Jul 22Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings
Apr 04Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade
Apr 02Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%
Feb 28CEO
Zhiming Jiang (51 yo)
1yr
Tenure
Ms. Zhiming Jiang is Managing Director and Director of Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. from 2024.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Board Secretary | 1.4yrs | CN¥1.09m | 0.029% CN¥ 25.3m | |
| MD & Director | 1yr | no data | no data | |
| Financial Director | 1yr | no data | no data |
1.0yrs
Average Tenure
49yo
Average Age
Experienced Management: 603392's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 1yr | no data | no data | |
| Chairman | 3.8yrs | CN¥2.05m | 3.54% CN¥ 3.1b | |
| Independent Director | 4yrs | CN¥120.00k | no data |
3.8yrs
Average Tenure
51yo
Average Age
Experienced Board: 603392's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/23 09:27 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Zhizhong Jing | China Merchants Securities Co. Ltd. |
| Wei Sun | China Merchants Securities Co. Ltd. |